Delivery Order SPE2DB22D3011-SPE2DB25FP9DX
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,009.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,665,266 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 4, 2024. It is not designated as a...
The federal contract award SPE2DB22D3016|SPE2DB25FAHA4, valued at $23,905.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,770,435 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of December 20, 2024. AmerisourceBergen holds a...
This federal contract award, valued at $2,712.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,510,655 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,566,197 tablets of Ondansetron HCL 4 mg. The contract has a ceiling value of $13,254.34 and runs through November 29, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNR59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,584,339 units of the drug Ondansetron HCL 4 mg Tablet. The contract has a ceiling value of $22,425.02 and a completion date of December 3, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen, the prime contractor, has a significant...
This federal contract award, identified as SPE2DB22D2006|SPE2DB25FV7JX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,827,485 units of Ondansetron HCL 4 mg tablets, which are used to treat nausea and vomiting. The contract has a ceiling value of $5,969.44 and runs through January 6, 2025. This award is not designated as a set-aside contract. The...
This federal contract award, with ID SPE2DB20D3505|SPE2DB23FT2G7, is a Delivery Order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,558,749,659 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $3,110.36 and a completion date of October 13, 2022. It is a Firm Fixed Price contract, with...
This is a $2,665.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,964,524 tablets of Ondansetron HCL 4 mg, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,203.33 fixed-price delivery order is for the supply of 4,559,216,399 units of Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of November 30, 2022 and was awarded on November 29, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, identified as SPE2DB20D1109|SPE2DB25FN39G, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,910,449 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $4,215.41 and is a Firm Fixed Price Delivery Order, with a completion date of January 14, 2025. The...